期刊
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
卷 29, 期 5-6, 页码 705-712出版社
KARGER
DOI: 10.1159/000178590
关键词
Systemic lupus erythematosus; Bone marrow mesenchymal stem cell; Transplantation; Cell cycle; Akt; GSK3 beta
资金
- National Natural Science Foundation of China [30972661]
- Science and Technology Foundation of Guangdong Province [2010B031600214]
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by activation and proliferation of autoreactive T cells and B cells. We examined changes in cell cycle progression of T cells from MRL/lpr mice with or without allogenic bone marrow mesenchymal stem cells (BMMSCs) treatment and analyzed the expression of cell cycle associated proteins. In addition, the Akt/GSK3 beta protein kinase cascade was studied. We demonstrated that high-dose MSCs transplantation effectively ameliorated disease activity in MRL/lpr mice. BMMSCs treatment inhibited G1/S transition of the abnormal lupus T lymphocytes. Moreover, it increased the expression of p21(WAF1/CIP1) and p27(Kip1) and decreased the expression of CDK2. Furthermore, high-dose MSCs inhibited abnormal activation of the Akt/GSK3 beta signaling pathway of T cells from MRL/lpr mice. Our results suggest that high-dose BMMSCs transplantation successfully treated MRL/lpr lupus mice by inhibiting abnormal activation of Akt/GSK3 beta signaling pathway of T cells. Copyright (c) 2012 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据